FRONT PHARMACOL 润色咨询

Frontiers in Pharmacology

出版年份：暂无数据 年文章数：13176 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：6.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2023-10-11 科研-小白 来自山西省

    Initial Validation大家用了多久，我提交原始数据第5天没动静

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2023-04-19 卡球球 zhao 来自广东省

    请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？
    Instructions for data sharing on Jianguoyun/Nutstore
    - Enter your Sync folder and create a folder entitled "Raw Data"
    - Upload all raw data and image files to this folder
    - Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file
    - Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially.

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2023-09-28 jobhnw 来自安徽省

    自引率6.3，国人占比100%，会踢么

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2023-10-10 桑葚大友 来自山东省

    请问大家review finalized以后几天？最后结果如何，谢谢大家。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2023-08-25 1378327198@qq.com 来自湖南省

    请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2022-12-08 南山晓月ZARD 来自辽宁省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：Meta分析
    经验分享：请问发表后pubmed上能检索到需要多长时间？

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2023-09-18 重复的用户名 来自浙江省

    补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2021-07-29 若氵离

    偏重的研究方向：心血管药理学
    经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2022-09-06 ms4000001680289394

    偏重的研究方向：民族药理学;中药复方
    经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄

    12

    展开12条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2126931, encodeId=f9b8212693172, content=请问一下各位大佬，原始数据太大怎么上传？坚果云没用过不大会，生成的共享链接放在哪里呀？<br>Instructions for data sharing on Jianguoyun/Nutstore<br>- Enter your Sync folder and create a folder entitled "Raw Data"<br>- Upload all raw data and image files to this folder<br>- Create a shareable link and include it in a Word document, uploaded as a Peer Review Only file<br>- Ensure that the sharing scope is set to Registered Users. Your data will be assessed confidentially., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Apr 19 01:00:40 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：Meta分析<br>经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1003537, encodeId=7ed3100353e7d, content=偏重的研究方向：心血管药理学<br>经验分享：请问朋友们，frontiers in pharmacology这个杂志社需不需要原始数据啊，我的文章现在处于Review Finalized，两个审稿人均已同意收稿，但是编辑提了不少问题。目前为止还未通知我上传原始记录，我想问下会要吗？大概什么时候要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38205516444, createdName=若氵离, createdTime=Thu Jul 29 10:20:59 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247445, encodeId=b238124e445bc, content=偏重的研究方向：民族药理学;中药复方<br>经验分享：投稿第三天就收到上传原始数据的邮箱了。实验结果的原始数据好好，第一次遇到连把数据库下载的原始数据也要提供😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Tue Sep 06 12:10:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133754, encodeId=26252133e54f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：综述<br>经验分享：09 May 2023 <br>Article accepted for publication.<br>02 May 2023 <br>Review of Review Editor 3 finalized.<br>28 Apr 2023 <br>Submitting Author posted new comments in the Editor tab.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>16 Apr 2023 <br>Reviewer 3 posted new comments.<br>15 Apr 2023 <br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>Submitting Author posted new comments in the Editor tab.<br>06 Apr 2023 <br>Interactive review forum activated.<br>05 Apr 2023 <br>Review of Reviewer 1 is finalized.<br>04 Apr 2023 <br>Review of Reviewer 2 is finalized.<br>23 Mar 2023 <br>Submitting Author submitted manuscrip, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64f46563607, createdName=ms1000000861767492, createdTime=Sun May 14 16:38:06 CST 2023, time=2023-05-14, status=1, ipAttribution=吉林省)]
    2023-05-14 ms1000000861767492 来自吉林省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：综述
    经验分享：09 May 2023
    Article accepted for publication.
    02 May 2023
    Review of Review Editor 3 finalized.
    28 Apr 2023
    Submitting Author posted new comments in the Editor tab.
    Submitting Author re-submitted manuscript.
    You posted new comments.
    16 Apr 2023
    Reviewer 3 posted new comments.
    15 Apr 2023
    Submitting Author re-submitted manuscript.
    You posted new comments.
    Submitting Author posted new comments in the Editor tab.
    06 Apr 2023
    Interactive review forum activated.
    05 Apr 2023
    Review of Reviewer 1 is finalized.
    04 Apr 2023
    Review of Reviewer 2 is finalized.
    23 Mar 2023
    Submitting Author submitted manuscrip

    3

    展开3条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分